// App-Quantinova.ai

1090 : Circulating tumor cells in metastatic breast cancer: Are they a strong and independent predictor of poor progression-free and overall survival-

Researchers

Presenter

  • Markus Wallwiener

Principal Investigators

  • Andreas Schneeweiss

  • Irene Baccelli

  • Volkmar Mueller

  • Brigitte Kathrin Rack

  • Christof Sohn

  • Erich-Franz Solomayer

  • Wolfgang Janni

  • Andreas D. Hartkopf

  • Tanja N. Fehm

  • Sabine Riethdorf

  • Klaus Pantel

  • Frederik Marme

  • Sarah Schott

  • Andreas Trumpp

  • Florin-Andrei Taran

  • Markus Hahn

  • Florian Schuetz

Medical Centers

  • Department of Obstetrics and Gynaecology, University of Heidelberg,, Heidelberg, Germany

  • University of Tuebingen, Department of Gynecology and Obstetrics, Tubingen, Germany

  • German Cancer Research Centre, Heidelberg, Germany

  • University of Tuebingen, Department of Gynecology and Obstetrics, Tubingen, Germany

  • Department of Gynecology and Obstetrics Ludwig-MaximiliansUniversity, Munich, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

  • Institute for Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Universitaetsklinikum Duesseldorf, Department of Gynecology and Obstetrics, Duesseldorf, Germany

  • Department of Gynecology and Obstetrics within the National Centre of Tumor Disease, University of Heidelberg, Heidelberg, Germany

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Department of Gynecology and Obstetrics, University of Tuebingen, Tuebingen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved